Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease.

ABSTRACT:

Background

Opioid use by patients with inflammatory bowel disease (IBD) has been associated with poorer health outcomes. This study describes socioeconomic characteristics; health utilization trends; and costs of patients with IBD and either no opioid prescriptions, or in 1 of 3 opioid duration categories based on Center for Disease Control guidelines: acute (0-30 days), moderate (31-90 days), or chronic (>90 days). We utilized the Cost of IBD Care Optum research database results for this study.

Methods

The Optum Research Database from years 2007 to 2016 including IBD patients with commercial or Medicare Advantage insurance in the United States was used. Additional inclusion criteria included continuous enrollment with medical and pharmacy benefit coverage for at least 24 mo

SUBMITTER: Szigethy EM 

PROVIDER: S-EPMC9802349 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature